Disease | cystic fibrosis |
Symptom | C0149725|lower respiratory tract infection |
Sentences | 1 |
PubMedID- 25533880 | Among several inhaled beta-lactams, ceftazidime was used with varying success in the prevention and treatment of ventilator-associated pneumonia (vap) and improved clinical outcomes in chronic pseudomonas aeruginosa lower respiratory tract infections (lrtis) in patients with cystic fibrosis (cf) or bronchiectasis. |
Page: 1